{
    "eid": "2-s2.0-85102900990",
    "title": "Effect of 5-HT2C receptor gene polymorphism (HTR2C\u2212759C/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone",
    "cover-date": "2021-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "-759C/T",
        "HTR2C",
        "hypertension",
        "metabolic adverse effects",
        "risperidone"
    ],
    "authors": [
        "Natchaya Vanwong",
        "Apichaya Puangpetch",
        "Weerapon Unaharassamee",
        "Napa Jiratjintana",
        "Chalitpon Na Nakorn",
        "Yaowaluck Hongkaew",
        "Chonlaphat Sukasem"
    ],
    "citedby-count": 1,
    "ref-count": 46,
    "ref-list": [
        "Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review",
        "Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication",
        "Metabolic syndrome in patients with schizophrenia",
        "The impact of weight gain on quality of life among persons with schizophrenia",
        "The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis",
        "Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis",
        "Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions",
        "Cardiovascular consequences of metabolic syndrome",
        "Pharmacogenetics of response to antipsychotics in patients with schizophrenia",
        "Which comes first: atypical antipsychotic treatment or cardiometabolic risk?",
        "Pharmacogenetics in psychiatry: how far are we from clinical application?",
        "Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat",
        "RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist",
        "Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors",
        "Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism",
        "Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes",
        "Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain",
        "Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample",
        "-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment",
        "Risperidone-related weight gain: genetic and nongenetic predictors",
        "Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals",
        "Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone",
        "Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients",
        "Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications",
        "Antipsychotic-associated weight gain: management strategies and impact on treatment adherence",
        "The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review",
        "Obesity as a risk factor for antipsychotic noncompliance",
        "Effectiveness of antipsychotic drugs in patients with chronic schizophrenia",
        "Risk of mortality (including sudden cardiac death) and major cardiovascular events in users of olanzapine and other antipsychotics: a study with the general practice research database",
        "Serotonergic control of metabolic homeostasis",
        "Serotonergic control of the organization of feeding and satiety",
        "5-HT(2C) receptor agonists and the control of appetite",
        "Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine",
        "Risperidone-induced adverse drug reactions and role of DRD2 (-141 C Ins/Del) and 5HTR2C (-759 C>T) genetic polymorphisms in patients with schizophrenia",
        "Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia",
        "The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients",
        "Consensus development conference on antipsychotic drugs and obesity and diabetes",
        "The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment",
        "Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications",
        "The underlying mechanisms for development of hypertension in the metabolic syndrome",
        "Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: the NHANES III Linked Mortality Study",
        "Serotonin and blood pressure regulation",
        "Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats",
        "5-hydroxtryptamine receptors in systemic hypertension: an arterial focus",
        "Hypothalamic serotonin release and raised blood pressure after raphe nuclei stimulation in rats",
        "Cardiovascular responses produced by microinjection of serotonin-receptor agonists into the paraventricular nucleus in conscious rats"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "112681896",
            "affilname": "Somdet Chaopraya Institute of Psychiatry",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112681896",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Somdet Chaopraya Institute of Psychiatry in central Thailand",
        "Chulalongkorn University",
        "Mahidol University",
        "Faculty of Allied Health Sciences"
    ]
}